{
  "nctId": "NCT02030821",
  "briefTitle": "TXA vs. Amicar in Total Knee and Hip Arthroplasty",
  "officialTitle": "TXA (Tranexamic Acid) vs. Amicar (Aminocaproic Acid) in Total Knee and Hip Arthroplasty- Effectiveness, Safety, and Cost Analysis",
  "protocolDocument": {
    "nctId": "NCT02030821",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2015-01-15",
    "uploadDate": "2018-10-24T10:53",
    "size": 220347,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02030821/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "PHASE4"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 246,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2015-01",
    "completionDate": "2017-11-12",
    "primaryCompletionDate": "2017-11-12",
    "firstSubmitDate": "2014-01-06",
    "firstPostDate": "2014-01-09"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Patients electing to undergo primary total hip or knee arthroplasty\n\nExclusion Criteria:\n\n* History of stents\n* Myocardial infarction,\n* Cerebrovascular accident or stroke\n* Deep venous thrombus\n* Pulmonary embolus\n* Late onset color blindness\n* Hypercoagulable state",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Total Blood Loss Over Course of Stay (Intraoperative and Postoperatively Until Discharge)",
        "timeFrame": "Participants will be followed for the duration of hospital stay, an expected average of 5 days"
      },
      {
        "measure": "Number of Transfusions",
        "timeFrame": "Participants will be followed for the duration of hospital stay, an expected average of 5 days"
      },
      {
        "measure": "Difference in Preoperative and Lowest Postoperative Hemoglobin",
        "timeFrame": "Participants will be followed for the duration of hospital stay, an expected average of 5 days"
      }
    ],
    "secondary": [
      {
        "measure": "Length of Hospitalization Stay",
        "timeFrame": "Participants will be followed for the duration of hospital stay, an expected average of 5 days"
      },
      {
        "measure": "Cost of Hospitalization",
        "timeFrame": "Participants will be followed for the duration of hospital stay, an expected average of 5 days"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 3,
      "secondaryCount": 2,
      "otherCount": 0,
      "totalCount": 5
    },
    "studyDesign": {
      "phases": [
        "PHASE4"
      ],
      "isRandomized": true,
      "isMasked": false,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 54,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-22T02:29:59.399Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}